Pages that link to "Q34365285"
Jump to navigation
Jump to search
The following pages link to Novel "anti-reverse" cap analogs with superior translational properties (Q34365285):
Displaying 50 items.
- Weak binding affinity of human 4EHP for mRNA cap analogs (Q24682514) (← links)
- Recombinant messenger RNA technology and its application in cancer immunotherapy, transcript replacement therapies, pluripotent stem cell induction, and beyond (Q26861563) (← links)
- Chemical synthesis and binding activity of the trypanosomatid cap-4 structure (Q30834243) (← links)
- Translation initiation factor eIF4G-1 binds to eIF3 through the eIF3e subunit (Q33246406) (← links)
- Applications of Phosphate Modification and Labeling to Study (m)RNA Caps (Q33578532) (← links)
- Structural requirements for Caenorhabditis elegans DcpS substrates based on fluorescence and HPLC enzyme kinetic studies (Q34010104) (← links)
- Towards mRNA with superior translational activity: synthesis and properties of ARCA tetraphosphates with single phosphorothioate modifications (Q34055104) (← links)
- Synthesis, properties, and biological activity of boranophosphate analogs of the mRNA cap: versatile tools for manipulation of therapeutically relevant cap-dependent processes (Q34249684) (← links)
- Novel cap analogs for in vitro synthesis of mRNAs with high translational efficiency (Q34366022) (← links)
- The antiviral drug ribavirin does not mimic the 7-methylguanosine moiety of the mRNA cap structure in vitro (Q34366602) (← links)
- Translation, stability, and resistance to decapping of mRNAs containing caps substituted in the triphosphate chain with BH3, Se, and NH (Q34807968) (← links)
- Enzymatic synthesis of RNAs capped with nucleotide analogues reveals the molecular basis for substrate selectivity of RNA capping enzyme: impacts on RNA metabolism (Q35005548) (← links)
- Distinct features of cap binding by eIF4E1b proteins (Q35013573) (← links)
- Two-headed tetraphosphate cap analogs are inhibitors of the Dcp1/2 RNA decapping complex. (Q35908793) (← links)
- Phosphorothioate cap analogs stabilize mRNA and increase translational efficiency in mammalian cells (Q36003386) (← links)
- Affinity resins containing enzymatically resistant mRNA cap analogs--a new tool for the analysis of cap-binding proteins (Q36060838) (← links)
- Biomaterials for mRNA delivery (Q36271488) (← links)
- A novel route for preparing 5' cap mimics and capped RNAs: phosphate-modified cap analogues obtained via click chemistry (Q36357301) (← links)
- Efficient preparation and properties of mRNAs containing a fluorescent cap analog: Anthraniloyl-m(7)GpppG (Q36380951) (← links)
- mRNAs containing the histone 3' stem-loop are degraded primarily by decapping mediated by oligouridylation of the 3' end. (Q36481212) (← links)
- Inhibition of Mitogen-activated Protein Kinase (MAPK)-interacting Kinase (MNK) Preferentially Affects Translation of mRNAs Containing Both a 5'-Terminal Cap and Hairpin (Q36573991) (← links)
- Synthesis and characterization of mRNA cap analogs containing phosphorothioate substitutions that bind tightly to eIF4E and are resistant to the decapping pyrophosphatase DcpS (Q36666301) (← links)
- Synthesis of anti-reverse cap analogs (ARCAs) and their applications in mRNA translation and stability (Q36965249) (← links)
- Identification of the HIT-45 protein from Trypanosoma brucei as an FHIT protein/dinucleoside triphosphatase: substrate specificity studies on the recombinant and endogenous proteins (Q37272413) (← links)
- Cap analogs modified with 1,2-dithiodiphosphate moiety protect mRNA from decapping and enhance its translational potential (Q37523030) (← links)
- Cap-dependent translation initiation factor eIF4E: an emerging anticancer drug target (Q38001940) (← links)
- Potential therapeutic applications of RNA cap analogs. (Q38116576) (← links)
- RNA-based tools for nuclear reprogramming and lineage-conversion: towards clinical applications. (Q38121503) (← links)
- mRNA-based therapeutics--developing a new class of drugs (Q38252360) (← links)
- mRNA transcript therapy (Q38264088) (← links)
- Stopped-flow kinetic analysis of eIF4E and phosphorylated eIF4E binding to cap analogs and capped oligoribonucleotides: evidence for a one-step binding mechanism (Q38314964) (← links)
- Differential inhibition of mRNA degradation pathways by novel cap analogs (Q38319346) (← links)
- Chemical synthesis of dinucleotide cap analogs (Q38336080) (← links)
- How To Form a Phosphate Anhydride Linkage in Nucleotide Derivatives. (Q38595373) (← links)
- Analysis of mononucleotides by tandem mass spectrometry: investigation of fragmentation pathways for phosphate- and ribose-modified nucleotide analogues (Q38615354) (← links)
- Advances in the delivery of RNA therapeutics: from concept to clinical reality. (Q38706445) (← links)
- Viral and Synthetic RNA Vector Technologies and Applications (Q38885624) (← links)
- Modified mRNA as a therapeutic tool to induce cardiac regeneration in ischemic heart disease (Q39027005) (← links)
- Treatment of breast and lung cancer cells with a N-7 benzyl guanosine monophosphate tryptamine phosphoramidate pronucleotide (4Ei-1) results in chemosensitization to gemcitabine and induced eIF4E proteasomal degradation. (Q39216345) (← links)
- Design and Facile Synthesis of New Dinucleotide Cap Analog Containing Both 2' and 3'-OH Modification on M⁷Guanosine Moiety. (Q40648279) (← links)
- Synthetic mRNA: Production, Introduction into Cells, and Physiological Consequences (Q40654970) (← links)
- mRNA cap analogues substituted in the tetraphosphate chain with CX2: identification of O-to-CCl2 as the first bridging modification that confers resistance to decapping without impairing translation (Q41630115) (← links)
- Synthesis and application of 2'-fluoro-substituted cap analogs (Q42192379) (← links)
- Synthesis and Substrate Validation of Cap Analogs Containing 7-Deazaguanosine Moiety by RNA Polymerase (Q42786889) (← links)
- Development of biochemical assays for the identification of eIF4E-specific inhibitors (Q43575401) (← links)
- Phosphorothioate cap analogs increase stability and translational efficiency of RNA vaccines in immature dendritic cells and induce superior immune responses in vivo (Q45858586) (← links)
- Deaggregation of eIF4E induced by mRNA 5' cap binding (Q46773186) (← links)
- Synthesis and enzymatic characterization of methylene analogs of adenosine 5'-tetraphosphate (P4A). (Q46773217) (← links)
- Novel dinucleoside 5',5'-triphosphate cap analogues. Synthesis and affinity for murine translation factor eIF4E. (Q46773234) (← links)
- Affinity of dinucleotide cap analogues for human decapping scavenger (hDcpS). (Q46860759) (← links)